News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Vitamin D boost fails to help deficient ICU patients
By Gene Emery (Reuters Health) - Curing the vitamin D deficiency of a patient in the intensive care unit (ICU) doesn't improve their odds of survival or recovery, a new study of 1,078 seriously-ill
Home has become the most common place of death in the U.S.
By Gene Emery (Reuters Health) - For the first time in a least a half century, home has surpassed the hospital as the leading place to die in the United States. A new analysis of death data, published
Major political events depress young doctors' moods
By Linda Carroll (Reuters Health) - Major U.S. political events, such as the 2016 presidential election and inauguration, were linked with declines in the moods of first-year residents, a new study
U.S. poised to give federal workers 12 weeks of paid parental leave
By Mike Stone WASHINGTON (Reuters) - More than 2 million federal workers will get paid parental leave for the first time, for 12 weeks, following a birth or adoption, under U.S. legislation poised to
Sexual dysfunction common after inguinal hernia repair in men
By Lisa Rapaport (Reuters Health) – Many men experience sexual dysfunction or pain during sexual activity after inguinal hernia surgery, a research review suggests. The authors analyzed data from 12
Two drugs show survival benefit in breast cancer, including one that slows brain metastases
By Gene Emery NEW YORK (Reuters Health) - New results from the HER2CLIMB and DESTINY-Breast01 studies show that trastuzumab deruxtecan can add 16 months of progression-free survival for women with
New Zealand burn surgeons taken to limits of expertise - specialist
By Reuters Staff LONDON (Reuters) - Surgical teams treating dozens of casualties suffering horrific burns after a deadly volcano eruption in New Zealand will be tested to the limits of their expertise
Decline in rural medical students likely to hurt rural physician workforce
By Carolyn Crist (Reuters Health) - The rural U.S. is already in dire need of more doctors, and with decreasing numbers of medical students coming from rural towns, the problem is likely to grow, a
U.S. diaper banks serve a fraction of families in need
By Lisa Rapaport (Reuters Health) - Many families living in poverty might benefit from diaper banks but don't receive this support, a U.S. study suggests. Nearly half of U.S. families with infants and
EXCLUSIVE-Swiss humanitarian channel to Iran seen within months - Swiss, U.S. officials
By Michael Shields and Stephanie Ulmer-Nebehay BERN (Reuters) - A humanitarian channel to bring food and medicine to Iran could be up and running within months, senior Swiss and U.S. officials told
Hotline launches to help Polish women travel abroad for abortion
By Sonia Elks LONDON (Thomson Reuters Foundation) - Women in Poland facing some of Europe's tightest restrictions on abortion will be offered advice and funding to travel abroad to get a termination
Non-cancer palliative care use growing
By Marilynn Larkin NEW YORK (Reuters Health) - Inpatient palliative care teams in the U.S. are caring for more patients with diagnoses other than cancer, starting care earlier in the disease course,
Balloon dilation seems safe, effective for sleeve gastrectomy stenosis
By Marilynn Larkin NEW YORK (Reuters Health) - Endoscopic balloon dilation (EBD) appears to be a safe, minimally invasive alternative to surgical revision for sleeve gastrectomy stenosis (SGS), a
REFILE-IVF with frozen embryos linked with higher risk for blastoma, leukemia
(Corrects spelling to Copperman, from Cooperman, in paragraphs 10-12) By Linda Carroll (Reuters Health) - When frozen embryos are used during in vitro fertilization (IVF), the resulting children have
Delhi's air turns hazardous again, government issues health warnings
By Reuters Staff NEW DELHI (Reuters) - Air quality in India's capital New Delhi plummeted to "severe" on Wednesday due to a drop in temperature and wind speed that trapped pollutants in the atmosphere
AstraZeneca-Daiichi drug halts cancer for months in first readout
By Reuters Staff (Reuters) - An experimental cancer drug developed by AstraZeneca and Daiichi Sankyo kept metastatic breast cancer at bay for months in women who had exhausted other treatment options,
Ixekizumab curbs disease activity, improves quality of life in axial spondyloarthritis
By Reuters Staff NEW YORK (Reuters Health) - Treatment with the interleukin-17 inhibitor ixekizumab (Taltz, Lilly) significantly improves signs and symptoms of non-radiographic axial spondyloarthritis
Pediatric migraine guidelines show limits of current research
By Anne Harding NEW YORK (Reuters Health) - New guidelines on pharmacological treatment for pediatric migraine underscore the need for more research to help the one-third of children and adolescents
Stem-cell transplant improves outcomes of high-risk sickle-cell disease
By Reuters Staff NEW YORK (Reuters Health) - Familial haploidentical stem-cell transplant improves outcomes in children and adolescents with high-risk sickle-cell disease, researchers report.
Drop in progenitor-cell levels during stress test may bode ill for heart patients
By David Douglas NEW YORK (Reuters Health) - In patients with stable coronary-artery disease (CAD), a reduction in circulating progenitor cell (CPC) counts during exercise stress testing is associated
Pediatricians' global health interest growing, but more training needed
By Marilynn Larkin NEW YORK (Reuters Health) - North American pediatricians' interest in global health participation has increased over the past 28 years, particularly among women and those past age
Brief PM 2.5 exposure tied to hospitalizations for wide range of illnesses
By Lisa Rapaport (Reuters Health) - Older adults exposed to PM 2.5 pollution, even for just a day or two, are more likely to be hospitalized for a wide variety of common health problems, a U.S. study
High schools often struggle to follow state concussion laws
By Lisa Rapaport (Reuters Health) - High schools across the U.S. face numerous barriers to implementing laws intended to help students recover from concussions, a small U.S. study suggests.
Many summer camps unprepared for allergic campers
By Lisa Rapaport (Reuters Health) - Although most summer camps welcome kids with food allergies, they often don't ask these campers to provide individualized emergency plans as a requirement for
IVF with frozen embryos linked with higher risk for blastoma, leukemia
By Linda Carroll (Reuters Health) - When frozen embryos are used during in vitro fertilization (IVF), the resulting children have a slightly higher risk for certain types of cancer, evidence from
Gunman kills six in Czech hospital waiting room before shooting himself
By Radovan Stoklasa OSTRAVA, Czech Republic (Reuters) - A 42-year-old gunman killed six people on Tuesday at a hospital waiting room in the eastern Czech city of Ostrava before fleeing and fatally
Correvio suffers fresh blow as heart drug fails to win FDA panel backing
By Dania Nadeem and Saumya Joseph (Reuters) - Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp's drug to correct irregular rhythm in the upper
Abdominal aortic aneurysm screening advice from USPSTF mostly unchanged
By Will Boggs MD NEW YORK (Reuters Health) - Updated recommendations from the U.S. Preventive Services Task Force (USPSTF) regarding screening for abdominal aortic aneurysm (AAA) mostly reiterate its
Rural U.S. sees slower decline in childhood deaths
By Carolyn Crist (Reuters Health) – Although mortality rates among U.S. infants, children and teens have declined overall in the last two decades, rural kids still face higher odds of death than urban
Bluebird bio, Bristol-Myers' multiple myeloma therapy shows promise in early study
By Saumya Joseph (Reuters) - Bluebird bio Inc and Bristol-Myers Squibb Co on Monday reported encouraging initial data from an ongoing early-stage study testing their experimental therapy for multiple
Sanofi ends research in diabetes, narrows units to spur profit
By Matthias Blamont PARIS (Reuters) - Sanofi SA said on Monday it would end its research efforts in diabetes and cardiovascular diseases as part of a revamp that will narrow the number of its business
U.S. Supreme Court justices lean toward insurers on $12 bln Obamacare claims
By Lawrence Hurley WASHINGTON (Reuters) - U.S. Supreme Court justices on Tuesday appeared sympathetic to claims made by health insurers seeking $12 billion from the federal government under a program
Medicare coverage for life in kidney recipients may save money
By Rob Goodier NEW YORK (Reuters Health) - Medicare may save money by taking on lifetime payments for immunosuppressant drugs after kidney transplantation, rather than the current policy that stops
Ferries halted, alarms triggered as Sydney choked by bushfire smoke
By Colin Packham and Jonathan Barrett SYDNEY (Reuters) - Smoke from Australia's fierce bushfires settled over Sydney in still conditions on Tuesday, setting off fire alarms, and halting ferry services
Fewer postpartum MS relapses during breastfeeding
By Will Boggs MD NEW YORK (Reuters Health) - Breastfeeding appears to protect against postpartum multiple sclerosis (MS) relapses, according to a fresh look at past research. "Breastfeeding did not
New model predicts six-month mortality for older adults with acute myocardial infarction
By Will Boggs MD NEW YORK (Reuters Health) - A new tool accurately predicts six-month mortality for older adults hospitalized with acute myocardial infarction (AMI), researchers report. "Our risk
Newer gadolinium-based contrast agents appear safe in patients with advanced CKD
By Megan Brooks NEW YORK (Reuters Health) - The risk of nephrogenic systemic fibrosis (NSF) with exposure to a group-II gadolinium-based contrast agent is "exceedingly low" in patients with stage-4 or
Immunosuppressive effects of cancer treatment increase mortality in people with HIV
By Will Boggs MD NEW YORK (Reuters Health) - Adults with HIV whose cancers are treated with chemotherapy or radiotherapy experience significant reductions in CD4 count, which are linked to increased
J&J CEO spurns U.S. congressional hearing on carcinogens in talc products
By Lisa Girion and Carl O'Donnell (Reuters) - Johnson & Johnson Chief Executive Officer Alex Gorsky has declined to appear at a U.S. congressional hearing set for Tuesday on the safety of the
Belgian boy wonder drops out of Dutch university at the age of 9
By Reuters Staff AMSTERDAM (Reuters) - A 9-year-old Belgian boy who was on track to become the world's youngest university graduate has terminated his studies at the Dutch university of Eindhoven
Bike-sharing company Wheels offers shareable helmet to cut injuries
By Reuters Staff DETROIT (Reuters) - Electric bike-sharing startup Wheels said on Tuesday it will begin offering its riders shareable helmets in response to concerns about injuries. Beginning in Los
Inaccuracies abound in OCT-angiography studies
By David Douglas NEW YORK (Reuters Health) - More than 90% of studies involving optical-coherence-tomography angiography (OCTA) fail to allow for the possible difference in axial length between the
Extending HPV vaccination ages costly with only small added health benefits
By Megan Brooks NEW YORK (Reuters Health) - Extending human papillomavirus (HPV) vaccination to middle-aged adults would be costly and likely yield only small added health benefits, according to a
Preterm infants face higher risk of diabetes in childhood, adulthood
By Lisa Rapaport (Reuters Health) - Premature babies may be more likely to develop diabetes as children and young adults than full-term infants, a new study suggests. Compared to kids under 18 years
Samoa says almost 90% of people vaccinated against measles after deadly outbreak
By Lidia Kelly MELBOURNE (Reuters) - Samoa said on Saturday nearly 90% of eligible people had been vaccinated against measles as it lifted a two-day curfew imposed amid an outbreak that has killed 65
Ranibizumab, aflibercept both effective for diabetic macular edema in real world
By Marilynn Larkin NEW YORK (Reuters Health) - Both ranibizumab and aflibercept effectively treat diabetic macular edema (DME), one-year data from a registry study reveal. Dr. Sanjeeb Bhandari of the
Risks differ for sudden unexpected infant versus neonatal deaths
By Marilynn Larkin NEW YORK (Reuters Health) - Sudden unexpected infant deaths (SUIDs) in the first week of life differ from those occurring later, a retrospective study reveals. Studies usually group
U.S. children not getting MMR vaccine before int'l travel
By Linda Carroll (Reuters Health) - Even with measles outbreaks common in many parts of the world, doctors and parents are often not opting to have children vaccinated before international travel, a
Brief visit to severely polluted city can up biomarkers of heart disease
By Saumya Joseph (Reuters Health) - Air pollution has often been linked with increased heart disease risk, but a "natural experiment" involving travelers to a city much more polluted than their own
Male aging linked to decreasing odds of live birth after IVF/ICSI
By Will Boggs MD NEW YORK (Reuters Health) - Male aging is associated with decreasing odds of live birth in in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles for idiopathic
REFILE-Endocrine-therapy benefit in ER-borderline breast cancer confirmed in real-world data
(Corrects formatting error in last line, no change to text) By Anne Harding NEW YORK (Reuters Health) - Endocrine therapy is associated with a reduced risk of recurrence in women with breast tumors
Promising early results from UM171-expanded cord-blood transplant
By Will Boggs MD NEW YORK (Reuters Health) - Preliminary results suggest that hematopoietic-stem-cell transplantation (HSCT) using UM171-expanded cord blood is feasible and safe in patients with
Endocrine-therapy benefit in ER-borderline breast cancer confirmed in real-world data
By Anne Harding NEW YORK (Reuters Health) - Endocrine therapy is associated with a reduced risk of recurrence in women with breast tumors expressing low levels of estrogen receptor (ER-borderline),
Adjunctive cenobamate effective for uncontrolled focal seizures
By Will Boggs MD NEW YORK (Reuters Health) - Adding cenobamate to existing antiepileptic treatment cuts seizure frequency in patients with uncontrolled focal seizures, according to findings from a
PREVIEW-Boston's trauma to be dissected as marathon bomber appeals death sentence
By Tim McLaughlin BOSTON (Reuters) - This city's deepest wound - the 2013 Boston Marathon bombings that killed three and injured hundreds more - will be re-examined Thursday when lawyers for bomber
U.S. Supreme Court leaves in place Kentucky abortion restriction
By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday left in place a Kentucky restriction requiring doctors to show and describe ultrasound images to women seeking an abortion,
Malaysia reports first case of polio since 1992
By Reuters Staff KUALA LUMPUR (Reuters) - A 3-month-old Malaysian infant has been diagnosed with polio, the first case reported in the country in nearly three decades, a top health official said on
Congo authorities say Ebola survivor falls ill a second time
By Fiston Mahamba GISENYI, Rwanda (Reuters) - An Ebola survivor has fallen ill with the disease for a second time in eastern Congo, the Congolese health authorities said on Sunday, saying it was not
Dutch gov't moves to ban laughing gas
By Reuters Staff AMSTERDAM (Reuters) - The Dutch government on Monday announced plans to include nitrous oxide - better known as laughing gas - on its "black list" of forbidden drugs, in response to a
Health experts warn of emerging threat of Nipah virus
By Reuters Health LONDON (Reuters) - A deadly virus called Nipah carried by bats has already caused human outbreaks across South and South East Asia and has "serious epidemic potential," global health
Russia banned from Olympics, World Cup and other big events for cheating over doping
By Brian Homewood and Gabrielle Tétrault-Farber LAUSANNE/MOSCOW (Reuters) - Russia was banned from the world's top sporting events for four years on Monday, a period that includes the next summer and
U.S. Supreme Court rejects Arizona opioid case against Purdue, Sackler family
By Nate Raymond WASHINGTON (Reuters) - The U.S. Supreme Court on Monday turned away a novel case by Arizona seeking to recover billions of dollars that the state has said that members of the Sackler
French regulator to ban some glyphosate products over health risks
By Reuters Staff PARIS (Reuters) - French health and environment agency ANSES said on Monday it was banning glyphosate-based weedkillers that represent most of the volume of such products sold in
REFILE-Omalizumab reduces atopic dermatitis severity, improves QOL in kids
(Corrects name of journal in para 4, and adds "not" to the final para, in story originally posted Nov 26.) By Anne Harding NEW YORK (Reuters Health) - Omalizumab reduces the severity of atopic
No survival difference between re-resection, percutaneous RFA in recurrent HCC
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with early-stage recurrent hepatocellular carcinoma (HCC), long-term survival does not differ between repeat hepatectomy and percutaneous
Weight-loss surgery between pregnancies tied to better maternal health
By Lisa Rapaport (Reuters Health) - Obese women who have weight-loss surgery between pregnancies may be less likely to experience complications like high blood pressure and preterm births in their
Teens have more nutritional deficiencies after gastric bypass vs sleeve gastrectomy
By Marilynn Larkin NEW YORK (Reuters Health) - More than twice as many teens who underwent Roux-en-Y gastric bypass (RYGB) for weight loss had multiple nutritional deficiencies compared to those who
Frequent tooth brushing linked with lower risk of afib, heart failure
By Lisa Rapaport (Reuters Health) - People who brush their teeth three times a day are less likely to develop atrial fibrillation or heart failure than those with less consistent oral hygiene habits,
FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, according to
Grifols says trial shows positive effects in Alzheimer's slow down
By Reuters Staff BARCELONA (Reuters) - Spain's Grifols said on Friday the latest results from a clinical trial of its Alzheimer's treatment show positive effects by achieving a reduction of the
Ice bath after workout may not improve fitness
By Linda Carroll (Reuters Health) - New research throws cold water on a popular exercise recovery regimen, finding that ice baths after a workout may actually impede muscle building. The study team
Switzerland's search dogs get ready for deadly avalanche season
By Reuters Staff LES DIABLERETS, Switzerland (Reuters) - Doctors and search dogs took to the skies in a helicopter on Friday to practice rescuing hikers and skiers in the build-up to the Swiss Alps'
Focused ultrasound opens blood-brain barrier, may aid Alzheimer's treatment
By Reuters Staff NEW YORK (Reuters Health) - MRI-guided low-intensity focused ultrasound (LIFU) can safely open the blood-brain barrier (BBB) and allow for targeted delivery of drugs in patients with
Bayer reaches agreement to postpone more glyphosate lawsuits for settlement talks
By Reuters Staff FRANKFURT (Reuters) - Germany's Bayer has agreed with plaintiffs to postpone its next two U.S. lawsuits over the alleged cancer-causing effects of its glyphosate-based weed killers to
UPDATE 1-Biogen builds case for its Alzheimer's drug, skeptics say more data needed
(Recasts story published Thursday, adds expert comments, background) By Deena Beasley and Julie Steenhuysen SAN DIEGO/CHICAGO (Reuters) - Biogen Inc on Thursday laid out more data on its experimental
Emotion-sensing robot launches to assist space station astronauts
By Joey Roulette WASHINGTON (Reuters) - An intelligent robot equipped with emotion-sensing voice detectors was headed to the International Space Station after launching from Florida on Thursday,
FDA probes diabetes drug metformin for carcinogen NDMA
By Carl O'Donnell and Ludwig Burger (Reuters) - The U.S. Food and Drug Administration and other healthcare regulators are investigating whether diabetes drug metformin had contaminations of a
Patient-reported outcomes predict survival in cancer trials
By Will Boggs MD NEW YORK (Reuters Health) - Patient-reported outcomes (PROs) independently predict overall survival in randomized clinical trials on cancer, according to a systematic review.
Quality-improvement project cuts albuterol use in kids with bronchiolitis
By Will Boggs MD NEW YORK (Reuters Health) - Changes in clinical pathways and order sets can help reduce albuterol use in children with bronchiolitis, researchers report. "Despite the large number of
Receiving preferred mental-health treatment reduces risk of dropping out of interventions
By Reuters Staff NEW YORK (Reuters Health) - Patients who receive the mental-health treatment of their choice are less likely to drop out of an intervention and have a stronger therapeutic alliance,
Multidisciplinary geriatric assessment may improve outcomes after stem-cell transplantation
By Will Boggs MD NEW YORK (Reuters Health) - Multidisciplinary, cancer-specific geriatric assessment to create an individualized optimization plan appears to improve outcomes in older patients
Enterotoxigenic E. coli vaccine safe, immunogenic in children in early trial
By Reuters Staff NEW YORK (Reuters Health) - An oral, inactivated enterotoxigenic Escherichia coli (ETEC) vaccine (ETVAX) is safe and immunogenic in children, according to a new phase-1/2 trial.
U.S. health spending recovers after two slow years: CMS
By Reuters Staff (Reuters) - U.S. healthcare spending recovered in 2018 after two consecutive years of decline, a government health agency reported on Thursday. The total national health expenditures
New York doctor convicted of taking kickbacks from opioid maker Insys
By Brendan Pierson NEW YORK (Reuters) - A New York doctor was convicted on Thursday of accepting thousands of dollars in bribes and kickbacks from Insys Therapeutics Inc in exchange for prescribing
1 in 3 U.S. high schools have no athletic trainers
By Carolyn Crist (Reuters Health) - One in every three high schools in the U.S. has no access to an athletic trainer, according to a large study. Even among the schools with some access, in roughly
Rural hospital acquisitions may reduce patient services
By Carolyn Crist (Reuters Health) - Although hospitals can improve financially when they join larger health systems, the merger may also reduce access to services for patients in rural areas,
Obesity may compromise response to sodium-channel blockers in AF patients
By David Douglas NEW YORK (Reuters Health) - In obese patients with atrial fibrillation (AF), antiarrhythmic therapy with sodium-channel blockers may lead to poor symptomatic control, researchers have
British hiker survives six-hour cardiac arrest in "exceptional" case - Spanish doctor
By Reuters Staff BARCELONA (Reuters) - A 34-year-old British hiker was revived in Spain after a six-hour cardiac arrest brought on by severe hypothermia, with the low mountain temperatures that made
U.S. vaping-related deaths rise to 48, cases of illness to 2,291
By Reuters Staff (Reuters) - U.S. health officials on Thursday reported one new case and one more death from a respiratory illness tied to vaping over a two-week period, taking the total death toll to
WHO decries "collective failure" as measles kills 140,000
By Kate Kelland LONDON (Reuters) - Measles infected nearly 10 million people in 2018 and killed 140,000, mostly children, as devastating outbreaks of the viral disease hit every region of the world,
